Latest Insights on ORGO
Pondering Put Selling, Snap’ed In Half & Amex’d Signals October 21, 2022 Great Stuff Friday Four Play: The “Reader Feedback” Edition? Great Ones, you’re getting a two-for today! It’s Friday Four Play and Reader Feedback … two great tastes that I hope taste great together. Dude, this is finance … not Reese’s. Why not both? Come on, you know that’s what you love about Great Stuff. We all know […]
The Digital Dollar Death Knell, Kroger Eats Albertsons & Un-Wells Fargo October 14, 2022 Great Stuff Friday Four Play: The “Executive Order 14067” Edition Great Ones, y’all know I’m not one for conspiracy theories. I’m more of a Occam’s Razor kinda guy. But you have a … kinda … sort of a beard? Anyway, you don’t shave! Geez, not that kinda razor. Occam’s Razor is a philosophical theory that basically states […]
This Special Situation Is Hiding in Plain Sight October 11, 2022 Investing, Real Talk, Stocks It involves three companies that were founded more than 100 years ago.
The Wrong Reason To Sell Tesla October 3, 2022 Great Stuff The Wrong Reason To Sell Tesla Great Ones, by now I’m sure you’re all aware of my mixed feelings about Tesla (Nasdaq: ). I’m all for green energy, electric vehicles (EVs), improving battery technology and all that jazz. At one point, I was even planning on making a Tesla my next car purchase. Those Model […]
Biogen’s Alzheimer’s All-Timer, Thor Thunders On, Cowardly Lionsgate September 28, 2022 Great Stuff Biogen’s Redemption Song Great Ones, so this ain’t the end, I saw Biogen (Nasdaq: ). Today, I had to turn my heart away. The news smelled like the sun, BIIB for everyone. And tales … it never fails. I’ve been lying so low in the weeds that Biogen’s latest Alzheimer’s drug ambushed me. It’s got […]MEET OUR EXPERTS
Chief Investment Strategist of Money & Markets
Research Analyst
Director of VIP Services
Editor of Strategic Fortunes and three elite services
